$935 Diabetes Jab Can Be Made for Less Than $5, Study Suggests

It costs Novo Nordisk less than $5 per month to produce its top-selling diabetes injection, Ozempic, even as it charges nearly $1,000 for a month’s supply before insurance, according to a new study. The study, published Wednesday in the journal JAMA Network Open, raises questions about the prohibitive cost of the popular diabetes treatment and other weight loss drugs that belong to a pricy class of medications based on GLP-1 technology. Those medicines work by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which stimulates the pancreas to release insulin when blood sugar rises too high, slows down the emptying of the stomach, and targets brain receptors involved in reducing appetite. Over the past year, demand for GLP-1 agonists has exploded despite soaring costs and limited insurance coverage....